Differential regulation of endothelial cell permeability by high and low doses of oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 3, 2012, Pages 331-341

  Starosta, Vitaliy ^a   Wu, Tinghuai ^a   Zimman, Alejandro ^b   Pham, Donald ^b   Tian, Xinyong ^a   Oskolkova, Olga ^c   Bochkov, Valery ^c   Berliner, Judith A ^b   Birukova, Anna A ^a   Birukov, Konstantin G ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Endothelium; Oxidized phospholipids; Permeability; Protein tyrosine phosphorylation; VE cadherin

Indexed keywords

1 PALMITOYL 2 ARACHIDONYL SN GLYCERO 3 PHOSPHOCHOLINE; ACETYLCYSTEINE; BETA CATENIN; PHOSPHORYLCHOLINE; PROTEIN P120; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DISSOCIATION; ELECTRIC RESISTANCE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; LUNG ALVEOLUS CELL; OXIDATION; PERMEABILITY BARRIER; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION;

ADHERENS JUNCTIONS; ANTIGENS, CD; BETA CATENIN; CADHERINS; CAPILLARY PERMEABILITY; CATENINS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; HUMANS; PHOSPHATIDYLCHOLINES; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; SRC-FAMILY KINASES; TIME FACTORS; TYROSINE;

EID: 84857778598     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0153OC     Document Type: Article

References (53)

1. Bochkov VN, Oskolkova OV, Birukov KG, Levonen AL, Binder CJ, Stockl J. Generation and biological activities of oxidized phospholipids. Antioxid Redox Signal 2010;12:1009-1059.
2. Chabot F, Mitchell JA, Gutteridge JM, Evans TW. Reactive oxygen species in acute lung injury. Eur Respir J 1998;11:745-757. (Pubitemid 28194873)
3. Lang JD, McArdle PJ, O'Reilly PJ, Matalon S. Oxidant-antioxidant balance in acute lung injury. Chest 2002;122:314S-320S. (Pubitemid 36043021)
4. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003;21:177-186. (Pubitemid 36150317)
5. Berliner JA, Gharavi NM. Endothelial cell regulation by phospholipid oxidation products. Free Radic Biol Med 2008;45:119-123.
6. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen R, Leung YH, Wang H, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008;133:235-249. (Pubitemid 351512299)
7. Ma Z, Li J, Yang L, Mu Y, Xie W, Pitt B, Li S. Inhibition of LPS- and CPG DNA-induced TNF-alpha response by oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 2004;286:L808-L816. (Pubitemid 38365067)
8. Nonas S, Birukova AA, Fu P, Xing J, Chatchavalvanich S, Bochkov VN, Leitinger N, Garcia JG, Birukov KG. Oxidized phospholipids reduce ventilator-induced vascular leak and inflammation in vivo. Crit Care 2008;12:R27.
9. Nonas SA, Miller I, Kawkitinarong K, Chatchavalvanich S, Gorshkova I, Bochkov VN, Leitinger N, Natarajan V, Garcia JG, Birukov KG. Oxidized phospholipids reduce vascular leak and inflammation in ratmodel of acute lung injury. Am J Respir Crit Care Med 2006;173:1130-1138. (Pubitemid 43726894)
10. Lee H, Shi W, Tontonoz P, Wang S, Subbanagounder G, Hedrick CC, Hama S, Borromeo C, Evans RM, Berliner JA, et al. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipidinduced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells. Circ Res 2000;87:516-521.
11. Yeh M, Gharavi NM, Choi J, Hsieh X, Reed E, Mouillesseaux KP, Cole AL, Reddy ST, Berliner JA. Oxidized phospholipids increase interleukin 8 (IL-8) synthesis by activation of the c-SRC/signal transducers and activators of transcription (STAT)3 pathway. J Biol Chem 2004; 279:30175-30181. (Pubitemid 38937941)
12. Shih PT, Elices MJ, Fang ZT, Ugarova TP, Strahl D, Territo MC, Frank JS, Kovach NL, Cabanas C, Berliner JA, et al. Minimally modified low-density lipoprotein induces monocyte adhesion to endothelial connecting segment-1 by activating beta1 integrin. J Clin Invest 1999;103:613-625. (Pubitemid 29122414)
13. Subbanagounder G, Leitinger N, Schwenke DC, Wong JW, Lee H, Rizza C, Watson AD, Faull KF, Fogelman AM, Berliner JA. Determinants of bioactivity of oxidized phospholipids: specific oxidized fatty acyl groups at the SN-2 position. Arterioscler Thromb Vasc Biol 2000;20:2248-2254.
14. Lee S, Gharavi NM, Honda H, Chang I, Kim B, Jen N, Li R, Zimman A, Berliner JA. A role for NADPH oxidase 4 in the activation of vascular endothelial cells by oxidized phospholipids. Free Radic BiolMed 2009;47:145-151.
15. Rouhanizadeh M, Hwang J, Clempus RE, Marcu L, Lassegue B, Sevanian A, Hsiai TK. Oxidized-1-palmitoyl-2-arachidonoyl-snglycero- 3-phosphorylcholine induces vascular endothelial superoxide production: implication of NADPH oxidase. Free Radic Biol Med 2005;39:1512-1522. (Pubitemid 41547231)
16. Ohkura N, Hiraishi S, Itabe H, Hamuro T, Kamikubo Y, Takano T, Matsuda J, Horie S. Oxidized phospholipids in oxidized low-density lipoprotein reduce the activity of tissue factor pathway inhibitor through association with its carboxy-terminal region. Antioxid Redox Signal 2004;6:705-712. (Pubitemid 38890787)
17. Marathe GK, Zimmerman GA, Prescott SM, McIntyre TM. Activation of vascular cells by PAF-like lipids in oxidized LDL. Vascul Pharmacol 2002;38:193-200. (Pubitemid 36398265)
18. Bochkov VN, Kadl A, Huber J, Gruber F, Binder BR, Leitinger N. Protective role of phospholipid oxidation products in endotoxininduced tissue damage. Nature 2002;419:77-81. (Pubitemid 34987873)
19. Birukov KG, Bochkov VN, Birukova AA, Kawkitinarong K, Rios A, Leitner A, Verin AD, Bokoch GM, Leitinger N, Garcia JG. Epoxycyclopentenone-containing oxidized phospholipids restore endothelial barrier function via Cdc42 and Rac. Circ Res 2004;95:892-901. (Pubitemid 39435004)
20. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008;121:2115-2122.
21. Birukova AA, Malyukova I, Poroyko V, Birukov KG. Paxillin-{beta}- catenin interactions are involved in Rac/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 2007;293:L199-L211. (Pubitemid 47080728)
22. Birukova AA, Fu P, Chatchavalvanich S, Burdette D, Oskolkova O, Bochkov VN, Birukov KG. Polar head groups are important for barrier protective effects of oxidized phospholipids on pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 2007;292:L924-L935. (Pubitemid 46608239)
23. Birukova AA, Chatchavalvanich S, Oskolkova O, Bochkov VN, Birukov KG. Signaling pathways involved in OxPAPC-induced pulmonary endothelial barrier protection. Microvasc Res 2007;73:173-181. (Pubitemid 46604761)
24. Birukova AA, Zebda N, Cokic I, Fu P, Wu T, Dubrovskyi O, Birukov KG. p190RhoGAP mediates protective effects of oxidized phospholipids in the models of ventilator-induced lung injury. Exp Cell Res 2011;317:859-872.
25. Watson AD, Leitinger N, Navab M, Faull KF, Horkko S, Witztum JL, Palinski W, Schwenke D, Salomon RG, Sha W, et al. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/ endothelial interactions and evidence for their presence in vivo. J Biol Chem 1997;272:13597-13607. (Pubitemid 27224791)
26. Birukov KG, Jacobson JR, Flores AA, Ye SQ, Birukova AA, Verin AD, Garcia JG. Magnitude-dependent regulation of pulmonary endothelialcell barrier function by cyclic stretch. Am J Physiol Lung Cell Mol Physiol 2003;285:L785-L797. (Pubitemid 37158824)
27. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JGN, Verin AD. Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction. Microvasc Res 2004;67:64-77. (Pubitemid 38050225)
28. Leitinger N, Tyner TR, Oslund L, Rizza C, Subbanagounder G, Lee H, Shih PT, Mackman N, Tigyi G, Territo MC, et al. Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils. Proc Natl Acad Sci USA 1999;96:12010-12015. (Pubitemid 29502849)
29. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC. Crystal structures of c-SRC reveal features of its autoinhibitory mechanism. Mol Cell 1999; 3:629-638. (Pubitemid 29268446)
30. Young MA, Gonfloni S, Superti-Furga G, Roux B, Kuriyan J. Dynamic coupling between the SH2 and SH3 domains of c-SRC and HCK underlies their inactivation by c-terminal tyrosine phosphorylation. Cell 2001;105:115-126. (Pubitemid 32323921)
31. Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, et al. Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med 2007;13:1086-1095. (Pubitemid 47517507)
32. Hammad LA, Wu G, Saleh MM, Klouckova I, Dobrolecki LE, Hickey RJ, Schnaper L, Novotny MV, Mechref Y. Elevated levels of hydroxylated phosphocholine lipids in the blood serum of breast cancer patients. Rapid Commun Mass Spectrom 2009;23:863-876.
33. Oskolkova OV, Afonyushkin T, Preinerstorfer B, Bicker W, von Schlieffen E, Hainzl E, Demyanets S, Schabbauer G, LindnerW, Tselepis AD, et al. Oxidized phospholipids are more potent antagonists of lipopolysaccharide than inducers of inflammation. J Immunol 2010;185:7706-7712.
34. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiol Rev 2006;86:279-367.
35. Birukova AA, Zebda N, Fu P, Poroyko V, Cokic I, Birukov KG. Association between adherens junctions and tight junctions via Rap1 promotes barrier protective effects of oxidized phospholipids. J Cell Physiol 2011;226:2052-2062.
36. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE. TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through Fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 2006;291:L1232-L1245. (Pubitemid 44904530)
37. Hudry-Clergeon H, Stengel D, Ninio E, Vilgrain I. Platelet-activating factor increases VE-cadherin tyrosine phosphorylation in mouse endothelial cells and its association with the PTDINS39-kinase. FASEB J 2005;19:512-520. (Pubitemid 40471242)
38. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 1998;111:1853-1865. (Pubitemid 28370530)
39. Zimman A, Chen SS, Komisopoulou E, Titz B, Martinez-Pinna R, Kafi A, Berliner JA, Graeber TG. Activation of aortic endothelial cells by oxidized phospholipids: a phosphoproteomic analysis. J Proteome Res 2010;9:2812-2824.
40. Alcaide P, Newton G, Auerbach S, Sehrawat S, Mayadas TN, Golan DE, Yacono P, Vincent P, Kowalczyk A, Luscinskas FW. p120-catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood 2008;112:2770-2779.
41. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120- and beta-catenin and maintains the cellular mesenchymal state. J Biol Chem 2005;280:31906-31912. (Pubitemid 41291941)
42. Birukov KG, Leitinger N, Bochkov VN, Garcia JG. Signal transduction pathways activated in human pulmonary endothelial cells by OxPAPC, a bioactive component of oxidized lipoproteins. Microvasc Res 2004;67:18-28. (Pubitemid 38050220)
43. DeMaio L, Rouhanizadeh M, Reddy S, Sevanian A, Hwang J, Hsiai TK. Oxidized phospholipids mediate occludin expression and phosphorylation in vascular endothelial cells. Am J Physiol Heart Circ Physiol 2006;290:H674-H683.
44. Lee JK, Edderkaoui M, Truong P, Ohno I, Jang KT, Berti A, Pandol SJ, Gukovskaya AS. NADPH oxidase promotes pancreatic cancer cell survival via inhibiting Jak2 dephosphorylation by tyrosine phosphatases. Gastroenterology 2007;133:1637-1648. (Pubitemid 350029743)
45. Chiarugi P. The redox regulation of LMW-PTP during cell proliferation or growth inhibition. IUBMB Life 2001;52:55-59. (Pubitemid 33769670)
46. Chiarugi P, Cirri P, Marra F, Raugei G, Fiaschi T, Camici G, Manao G, Romanelli RG, Ramponi G. The Src and signal transducers and activators of transcription pathways as specific targets for low molecular weight phosphotyrosine-protein phosphatase in plateletderived growth factor signaling. J Biol Chem 1998;273:6776-6785. (Pubitemid 28160340)
47. Taddei ML, Chiarugi P, Cuevas C, Ramponi G, Raugei G. Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug aplidin. Int J Cancer 2006;118:2082-2088.
48. Taddei ML, Chiarugi P, Cirri P, Buricchi F, Fiaschi T, Giannoni E, Talini D, Cozzi G, Formigli L, Raugei G, et al. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherinmediated cell-cell adhesion increase. Cancer Res 2002;62:6489-6499. (Pubitemid 35364113)
49. Monaghan-Benson E, Burridge K. The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 2009;284:25602-25611.
50. Nimnual AS, Taylor LJ, Bar-Sagi D. Redox-dependent downregulation of Rho by Rac. Nat Cell Biol 2003;5:236-241. (Pubitemid 36322251)
51. Lambeng N, Wallez Y, Rampon C, Cand F, Christe G, Gulino-Debrac D, Vilgrain I, Huber P. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res 2005;96:384-391. (Pubitemid 40279914)
52. Weis S, Cui J, Barnes L, Cheresh D. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol 2004;167:223-229. (Pubitemid 39435066)
53. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, et al. Src blockade stabilizes a FLK/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 2004;113:885-894. (Pubitemid 38544147)